{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:26:49Z","timestamp":1776122809620,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1124\/jpet.111.185108","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T03:54:51Z","timestamp":1312602891000},"page":"555-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Pharmacological Characterization of 2-Methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a High-Affinity Antagonist Selective for \u03ba-Opioid Receptors"],"prefix":"10.1016","volume":"339","author":[{"given":"S.","family":"Grimwood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Vanase-Frawley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sawant-Basak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.R.","family":"Verhoest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.185108_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1208\/s12248-009-9105-4","article-title":"Peptide \u03ba opioid receptor ligands: potential for drug development","volume":"11","author":"Aldrich","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/jpet.111.185108_bib2","doi-asserted-by":"crossref","first-page":"18396","DOI":"10.1073\/pnas.0910180106","article-title":"Zyklophin, a systemically active selective \u03ba opioid receptor peptide antagonist with short duration of action","volume":"106","author":"Aldrich","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.111.185108_bib3","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11055-005-0146-6","article-title":"A model of anxious depression: persistence of behavioral pathology","volume":"35","author":"Avgustinovich","year":"2005","journal-title":"Neurosci Behav Physiol"},{"key":"10.1124\/jpet.111.185108_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel \u03ba opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.185108_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1120972","article-title":"Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress","volume":"311","author":"Berton","year":"2006","journal-title":"Science"},{"key":"10.1124\/jpet.111.185108_bib6","series-title":"at the Society for Neuroscience Annual Meeting; 2010 Nov 13\u201317; San Diego, CA.","article-title":"Comparative anatomical distribution of kappa opioid receptors in human, non-human primate, guinea-pig and rodent brains","author":"Bian","year":"2010"},{"key":"10.1124\/jpet.111.185108_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00213-004-2138-6","article-title":"Influence of the dose and the number of drug-context pairings on the magnitude and the long-lasting retention of cocaine-induced conditioned place preference in C57BL\/6J mice","volume":"180","author":"Brabant","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.185108_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/\u03ba opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res"},{"key":"10.1124\/jpet.111.185108_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainresrev.2009.09.008","article-title":"\u03ba-Opioid receptor signaling and brain reward function","volume":"62","author":"Bruijnzeel","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1124\/jpet.111.185108_bib10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.106.112417","article-title":"Effects of salvinorin A, a \u03ba-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high \u03ba-receptor homology to humans","volume":"320","author":"Butelman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.185108_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2007.05.007","article-title":"Reinstatement of cocaine place-conditioning prevented by the peptide \u03ba-opioid receptor antagonist arodyn","volume":"569","author":"Carey","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.185108_bib12","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-011-9296-3","article-title":"Quantitative PK-PD model-based translational pharmacology of a novel \u03ba opioid receptor antagonist between rats and humans","author":"Chang","year":"2011","journal-title":"J AAPS"},{"key":"10.1124\/jpet.111.185108_bib13","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.111.185108_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)03823-6","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D\u2019Amour","year":"1941","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.185108_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.1996.67031309.x","article-title":"Functional coupling of the \u03b4-, \u03bc-, and \u03ba-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells","volume":"67","author":"Fukuda","year":"1996","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.185108_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pnpbp.2005.10.007","article-title":"Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: a retrospective study","volume":"30","author":"Gerra","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.111.185108_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0376-8716(98)00104-5","article-title":"Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine","volume":"53","author":"Greenwald","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.111.185108_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pharmthera.2009.03.002","article-title":"Target site occupancy: emerging generalizations from clinical and preclinical studies","volume":"122","author":"Grimwood","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.111.185108_bib19","series-title":"Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics","first-page":"547","article-title":"Opioid analgesics","author":"Gutstein","year":"2006"},{"key":"10.1124\/jpet.111.185108_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","article-title":"Neural mechanisms of addiction: the role of reward-related learning and memory","volume":"29","author":"Hyman","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/jpet.111.185108_bib21","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/jpet.111.185108_bib22","series-title":"at the Society for Neuroscience Annual Meeting; 2010 Nov 13\u201317; San Diego, CA.","article-title":"Central receptor occupancy and pharmacodynamic action of PF-04455242, a high affinity, selective \u03ba opioid receptor antagonist, in humans","author":"Jacobsen","year":"2010"},{"key":"10.1124\/jpet.111.185108_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002130100918","article-title":"Social defeat alters the acquisition of cocaine self-administration in rats: role of individual differences in cocaine-taking behavior","volume":"158","author":"Kabbaj","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.185108_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.40.1.389","article-title":"Molecular mechanisms and regulation of opioid receptor signaling","volume":"40","author":"Law","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.111.185108_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of \u03ba-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.185108_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","article-title":"Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.111.185108_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-3565(25)23043-9","article-title":"\u03ba Opioid receptor-mediated regulation of dopaminergic neurons in the rat brain","volume":"256","author":"Manzanares","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.185108_bib28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/sj.npp.1300872","article-title":"Social defeat stress-induced behavioral responses are mediated by the endogenous \u03ba opioid system","volume":"31","author":"McLaughlin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.111.185108_bib29","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"\u03ba Opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.111.185108_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(02)02872-8","article-title":"Naloxone displacement at opioid receptor sites measured in vivo in the human brain","volume":"459","author":"Melichar","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.111.185108_bib31","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.111.074195","article-title":"Duration of action of a broad range of selective \u03ba-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation","volume":"80","author":"Melief","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.111.185108_bib32","doi-asserted-by":"crossref","first-page":"E704","DOI":"10.1208\/aapsj070371","article-title":"\u03ba Opioid antagonists: past successes and future prospects","volume":"7","author":"Metcalf","year":"2005","journal-title":"AAPS J"},{"key":"10.1124\/jpet.111.185108_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1208\/s12248-010-9191-3","article-title":"Identification of two novel, potent, low-liability antinociceptive compounds from the direct in vivo screening of a large mixture-based combinatorial library","volume":"12","author":"Reilley","year":"2010","journal-title":"AAPS J"},{"key":"10.1124\/jpet.111.185108_bib34","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous \u03ba opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.111.185108_bib35","first-page":"55","article-title":"Defining neuropharmacokinetic parameters in CNS drug discovery to determine cross-species pharmacologic exposure-response relationships","volume":"45","author":"Shaffer","year":"2010","journal-title":"Annu Rep Med Chem"},{"key":"10.1124\/jpet.111.185108_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.111.185108_bib37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(02)00102-X","article-title":"Unconditioned and conditioned factors contribute to the \u2018reinstatement\u2019 of cocaine place conditioning following extinction in C57BL\/6 mice","volume":"136","author":"Szumlinski","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.111.185108_bib38","first-page":"484","article-title":"11C-GR103545, a radiotracer for imaging \u03ba-opioid receptors in vivo with PET: synthesis and evaluation in baboons","volume":"46","author":"Talbot","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1124\/jpet.111.185108_bib39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.bjp.0700971","article-title":"The effects of spiradoline (U-62066E), a \u03ba-opioid receptor agonist, on neuroendocrine function in man","volume":"120","author":"Ur","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.185108_bib40","doi-asserted-by":"crossref","DOI":"10.1021\/jm2006035","article-title":"Design and discovery of a selective small-molecule \u03ba opioid antagonist (2-methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF-4455242)","author":"Verhoest","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.111.185108_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","article-title":"Enadoline, a selective \u03ba opioid agonist: comparison with butorphanol and hydromorphone in humans","volume":"157","author":"Walsh","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1124\/jpet.111.185108_bib42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/aps.2010.138","article-title":"The role of \u03ba-opioid receptor activation in mediating antinociception and addiction","volume":"31","author":"Wang","year":"2010","journal-title":"Acta Pharmacol Sin"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524466238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524466238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.185108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T22:47:23Z","timestamp":1743202043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524466238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0022356524466238"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.185108","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization of 2-Methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a High-Affinity Antagonist Selective for \u03ba-Opioid Receptors","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.185108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}